Search Within

Lara Dunn

Formats
  1. Meeting Abstract (81)
  2. Journal Article (50)
  3. Review (7)
  4. Book Section (1)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (141)
  2. Head and Neck Service (141)
  3. Solid Tumor Oncology Division (141)
  4. Weinberg Fellows (141)
  5. Radiation Oncology, Department of (72)
  6. Surgery (65)

More Groups

People
  1. Eric Sherman (77)
  2. David Pfister (60)
  3. Nancy Lee (60)
  4. Sean McBride (57)
  5. Alan Ho (54)
  6. Nadeem Riaz (52)

More People

Years
  1. 2025 (3)
  2. 2024 (22)
  3. 2023 (10)
  4. 2022 (11)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (41)
  2. International Journal of Radiation Oncology, Biology, Physics (24)
  3. Annals of Oncology (9)
  4. Journal for ImmunoTherapy of Cancer (8)
  5. Head & Neck (6)
  6. Oral Oncology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (43)
  2. Elsevier Inc. (30)
  3. Oxford University Press (10)
  4. Biomed Central Ltd (8)
  5. John Wiley & Sons, Inc. (6)
  6. Wiley Blackwell (6)

More Publishers

Results (141)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase Ib study of cetuximab + BYL719 + IMRT in stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Riaz, N.; Baxi, S. S.; McBride, S. M.; Sherman, E. J.; Michel, L.; Haque, S.; Katabi, N.; Wong, R. J.; Xiao, H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The natural history and patterns of failure after recurrence in patients with locally advanced head and neck squamous cell carcinoma treated with modern chemoradiation techniques
    Meeting Abstract

    Leeman, J.; Li, J. G.; Pei, X.; Venigalla, P.; Zumsteg, Z.; Katsoulakis, E.; Lupovitch, E.; McBride, S.; Tsai, J.; Boyle, J.; more...
    Journal of Radiation Oncology (2017)

    Fulltext@MSK | Save
  • Overcoming acquired resistance to PI3K inhibitors in head and neck squamous cell carcinoma with combination treatment
    Meeting Abstract

    Mizrachi, A.; Dunn, L.; Ho, A.; Scaltriti, M.
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Long-term survival in oligometastatic head and neck cancer
    Meeting Abstract

    Leeman, J. E.; Patel, S.; Anderson, E. S.; Spielsinger, D.; Tsai, C. J.; McBride, S.; Dunn, L.; Sherman, E.; Lee, N.; Riaz, N.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques
    Journal Article

    Leeman, J. E.; Li, J. G.; Pei, X.; Venigalla, P.; Zumsteg, Z. S.; Katsoulakis, E.; Lupovitch, E.; McBride, S. M.; Tsai, C. J.; Boyle, J. O.; more...
    JAMA Oncology (2017)

    Fulltext@MSK | Save
  • A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Dunn, L. A.; Fury, M. G.; Xiao, H.; Baxi, S. S.; Sherman, E. J.; Korte, S.; Pfister, C.; Haque, S.; Katabi, N.; Ho, A. L.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer
    Journal Article

    Sherman, E. J.; Dunn, L. A.; Ho, A. L.; Baxi, S. S.; Ghossein, R. A.; Fury, M. G.; Haque, S.; Sima, C. S.; Cullen, G.; Fagin, J. A.; more...
    Cancer (2017)

    Fulltext@MSK | Save
  • Predictors of outcome in adenoid cystic carcinoma of salivary glands: A clinicopathologic study with correlation between MYB fusion and protein expression
    Journal Article

    Xu, B.; Drill, E.; Ho, A.; Ho, A.; Dunn, L.; Prieto-Granada, C. N.; Chan, T.; Ganly, I.; Ghossein, R.; Katabi, N.
    American Journal of Surgical Pathology (2017)

    Fulltext@MSK | Save
  • Enhancing radioiodine (RAI) incorporation into BRAF(V600E)-mutant, RAI-refractory thyroid cancers with the BRAF inhibitor vemurafenib: A pilot study
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Baxi, S. S.; Grewal, R. K.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M.; Fish, S.; Boucai, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Unmet needs for patients with salivary gland cancer
    Journal Article

    Dunn, L. A.; Ho, A. L.; Laurie, S. A.; Pfister, D. G.
    Oral Oncology (2016)

    Fulltext@MSK | Save